Document Detail


L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis.
MedLine Citation:
PMID:  18503218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Patients on long-term hemodialysis become deficient in carnitine and are frequently treated with carnitine supplementation to offset their renal anemia, lipid abnormality and cardiac dysfunction. The therapeutic value of carnitine supplementation on left ventricular hypertrophy (LVH) in patients with normal cardiac systolic function remains uncertain. METHODS AND RESULTS: The cardiac morphology and function of 10 patients given 10 mg/kg of L-carnitine orally, immediately after hemodialysis sessions 3 times per week for a 12-month period were compared with 10 untreated control patients. Using echocardiography, left ventricular fractional shortening (LVFS) and left ventricular mass index (LVMI) were measured before and after the study period. As a result, amounts of serum-free carnitine increased from 28.4+/-4.7 to 58.5+/-12.1 micromol/L. The LVMI decreased significantly from 151.8+/-21.2 to 134.0+/-16.0 g/m(2) in treated patients (p<0.01), yet the LVMI in untreated control patients did not change significantly (ie, from 153.3+/-28.2 to 167.1+/-43.1 g/m(2)). However, LVFS values remained unchanged in both groups. Although L-carnitine promoted a 31% reduction in erythropoietin requirements, hematocrit and blood pressure did not change during the study period. CONCLUSIONS: Supplementation with L-carnitine induced regression of LVH in patients on hemodialysis, even for those with normal systolic function.
Authors:
Tai Sakurabayashi; Shigeru Miyazaki; Yasuko Yuasa; Shinji Sakai; Masashi Suzuki; Sachio Takahashi; Yoshihei Hirasawa
Related Documents :
19608128 - Real-time 3-dimensional echocardiographic assessment of left ventricular dyssynchrony: ...
16702588 - Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus ...
15200118 - Correlation between decreased ventricular size and positive clinical outcome following ...
624168 - Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis.
18039638 - Oxidative stress and ferritin levels in haemodialysis patients.
942298 - Metastatic carcinoma of the ureter.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Multicenter Study    
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  72     ISSN:  1346-9843     ISO Abbreviation:  Circ. J.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-26     Completed Date:  2008-09-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  926-31     Citation Subset:  IM    
Affiliation:
Kidney Center of Shinraku-en Hospital, 3-1-1 Shindori-minami, Niigata 950-2087, Japan. t-sakura@db3.so-net.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Blood Pressure
Body Weight
Carnitine / administration & dosage*
Echocardiography
Female
Hematocrit
Humans
Hypertrophy, Left Ventricular / complications,  drug therapy*,  ultrasonography
Kidney Failure, Chronic / complications*,  therapy
Male
Middle Aged
Renal Dialysis*
Treatment Outcome
Vitamin B Complex / administration & dosage*
Chemical
Reg. No./Substance:
12001-76-2/Vitamin B Complex; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation.
Next Document:  Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoa...